A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

Genetic testing analyzes a person's DNA to determine their risk for certain diseases. It was a game-changer for one Montgomery County woman. Genetic testing is a simple mouth swab that can uncover ...

A genetic risk score could one day guide more personalized treatment for high-risk women, while sparing low-risk women from unnecessary procedures. A new genetic analysis could help predict whether ...

Treatment for stage 2 essential thrombocythemia is highly personalized. Not every patient requires medication right away, and ...

Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a ...